Biological therapies: A novel approach to the treatment of autoimmune disease☆,☆☆
References (15)
The future of biologics in the treatment of rheumatoid arthritis
Semin Arthritis Rheum.
(1994)- et al.
Humanised monoclonal antibody therapy for rheumatoid arthritis
Lancet
(1992) - et al.
Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis
Lancet
(1994) - et al.
New directions for biological therapy in rheumatoid arthritis
Int Arch Allergy Immunol.
(1994) - et al.
Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis
Arthritis Rheum.
(1993) - et al.
Administration of F(ab′)2 fragments of monoclonal antibody to L3T3 inhibits humoral immunity in mice without depleting L3T4+ cells
J Immunol.
(1986)
There are more references available in the full text version of this article.
Cited by (0)
- ☆
This work is supported by National Institutes of Health grant AR38477, by the Specialized Center of Research in Rheumatoid Arthritis, and by the Multipurpose Arthritis and Musculoskeletal Diseases Center at the University of Michigan.
- ☆☆
Department of Internal Medicine, Division of Rheumatology, Room 3918 Taubman Center, Box 0358, The University of Michigan Medical Center, Ann Arbor, Michigan 48109-0358.
Copyright © 1995 Published by Excerpta Medica Inc.